Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$524M |
| 2 |
Peloton Interactive
PTON
|
+$465M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$290M |
| 5 |
Snap
SNAP
|
+$262M |
Top Sells
| 1 |
Zoom
ZM
|
+$965M |
| 2 |
Pinduoduo
PDD
|
+$805M |
| 3 |
AbbVie
ABBV
|
+$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.18% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
iShares MSCI South Korea ETF
EWY
$5.6B
| $774K | ﹤0.01% |
9,000
-83,764
| -90% | -$7.2M |
|
2627
Lendway
LDWY
$8.76M
| $774K | ﹤0.01% |
131,612
+14,072
| +12% | +$82.8K |
|
2628
Meridian
MRBK
$175M
| $772K | ﹤0.01% |
74,240
+50,058
| +207% | +$521K |
|
2629
Scholastic
SCHL
$683M
| $770K | ﹤0.01% |
30,801
-24,898
| -45% | -$622K |
|
|
PLXP
2630
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $768K | ﹤0.01% |
139,083
+61,400
| +79% | +$339K |
|
2631
Forward Air
FWRD
$901M
| $764K | ﹤0.01% |
9,939
-70,300
| -88% | -$5.4M |
|
2632
SemiLEDS
LEDS
$17.3M
| $762K | ﹤0.01% |
212,896
-5,500
| -3% | -$19.7K |
|
|
APEN
2633
DELISTED
Apollo Endosurgery, Inc.
APEN
| $761K | ﹤0.01% |
223,800
+121,900
| +120% | +$415K |
|
2634
Moleculin Biotech
MBRX
$11.9M
| $756K | ﹤0.01% |
10,539
+637
| +6% | +$45.7K |
|
|
EBTC
2635
DELISTED
Enterprise Bancorp
EBTC
| $755K | ﹤0.01% |
29,548
-3,052
| -9% | -$78K |
|
2636
Synlogic
SYBX
$20.4M
| $754K | ﹤0.01% |
23,287
+4,972
| +27% | +$161K |
|
2637
Xtant Medical Holdings
XTNT
$91M
| $751K | ﹤0.01% |
627,690
+251,002
| +67% | +$300K |
|
|
AMK
2638
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $750K | ﹤0.01% |
+31,000
| New | +$750K |
|
2639
BGSF Inc
BGSF
$78.9M
| $749K | ﹤0.01% |
55,501
-22,047
| -28% | -$298K |
|
2640
ESSA Pharma
EPIX
$9.59M
| $749K | ﹤0.01% |
62,803
-28,997
| -32% | -$346K |
|
2641
Mirum Pharmaceuticals
MIRM
$3.67B
| $749K | ﹤0.01% |
+42,900
| New | +$749K |
|
|
OPTN
2642
DELISTED
OptiNose
OPTN
| $749K | ﹤0.01% |
12,060
+3,800
| +46% | +$236K |
|
2643
World Kinect Corp
WKC
$1.45B
| $748K | ﹤0.01% |
+24,000
| New | +$748K |
|
|
ORTX
2644
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $748K | ﹤0.01% |
17,307
+13,353
| +338% | +$577K |
|
2645
Leap Therapeutics
LPTX
$13.2M
| $744K | ﹤0.01% |
33,050
-36,820
| -53% | -$829K |
|
2646
Constellium
CSTM
$2.13B
| $740K | ﹤0.01% |
+52,900
| New | +$740K |
|
2647
KBR
KBR
$6.21B
| $739K | ﹤0.01% |
+23,900
| New | +$739K |
|
|
GFED
2648
DELISTED
Guaranty Federal Bancshares In
GFED
| $737K | ﹤0.01% |
42,200
-100
| -0.2% | -$1.75K |
|
2649
Investar Holding Corp
ISTR
$221M
| $736K | ﹤0.01% |
44,475
+6,100
| +16% | +$101K |
|
2650
HF Foods Group
HFFG
$182M
| $735K | ﹤0.01% |
97,700
-87,700
| -47% | -$660K |
|